| 1 | CCNE1, CD79A, POU2AF1
|
| BOB.1, CD79a and cyclin E are the most appropriate markers to discriminate classical Hodgkin's lymphoma from primary mediastinal large B-cell lymphoma.
|
| Hoeller S, Zihler D, Zlobec I, Obermann EC, Pileri SA, Dirnhofer S, Tzankov A.
|
| Histopathology 56(2):217-28.
2010
|
| 2 | AGM3, CD79A
|
| Novel Igalpha (CD79a) gene mutation in a Turkish patient with B cell-deficient agammaglobulinemia.
|
| Wang Y, Kanegane H, Sanal O, Tezcan I, Ersoy F, Futatani T, Miyawaki T.
|
| Am J Med Genet 108(4):333-6. 2002
|
| 3 | AGM3, CD79A
|
| Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
|
| Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley ME.
|
| J Clin Invest 104(8):1115-21. 1999
|
| 4 | CD79A
|
| Structure, chromosomal localization, and methylation pattern of the human mb-1 gene.
|
| Ha H, et al.
|
| J Immunol 152 : 5749-5757. 1994
|
| 5 | CD79A
|
| Chromosomal localization, genomic struture, and allelic polymorphism of the human CD79a (Ig-alpha/mb-1) gene.
|
| Hashimoto S, et al.
|
| Immunogenetics 40 : 287-295. 1994
|
| 6 | CD79A
|
| RFLP detected by the transmembrane exon probe of the human immunoglobulin IGHA genes.
|
| Bensmana M, et al.
|
| Nucleic Acids Res 19 : 5098. 1991
|